ONC Director Exercises Options and Sells Shares Worth $896k
BeOne Medicines Ltd.
Subscribe to track ONC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
ONC Director Exercises Options, Sells $896k in Stock
Company: BeOne Medicines Ltd. (ONC) Form: 4 | Filed: 2025-12-01 Significance: Low
Insider: Sanders Corazon (Corsee) D. Title: null | Relationship: Director
Transaction: • Type: Exercise & Sell • Shares Sold: 2,627 ADSs • Avg. Price: ~$341.00 • Value: $895,544 • ADSs Owned After: 0
Key Insight: A director exercised vested options and immediately sold the acquired shares, a common practice for compensation. The transaction value is insignificant relative to the company's $40.48B market cap.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: BeOne Medicines Ltd. (ONC)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director conducted a routine "exercise-and-sell" transaction, realizing value from vested options with a total sale value of approximately $896k.
- Market Impact: The transaction is negligible compared to the company's $40.48 billion market capitalization and is unlikely to influence the market.
Company Information
| Field | Value |
|---|---|
| Company | BeOne Medicines Ltd. |
| Ticker Symbol | ONC |
| CIK | 0001651308 |
| Industry | PHARMACEUTICAL PREPARATIONS [2834] |
Insider Information
| Field | Value |
|---|---|
| Name | Sanders Corazon (Corsee) D. |
| CIK | 0001796536 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
This filing reports an option exercise followed by immediate sales.
Combined Sale Transaction:
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-26 |
| Transaction Code | S (Sale) |
| Security Type | American Depositary Shares |
| Shares Involved | 2,627 |
| Price Per Share | ~$341.00 (Weighted Average) |
| Total Value | $895,544.43 |
| Shares Owned After | 0 (of this security type) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $895,544 |
| % of Market Cap | 0.0022% |
| Shares Transacted | 2,627 ADSs |
| % of Shares Outstanding | Not Available |
| Post-Transaction Ownership | 57,226 Ordinary Shares |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The sale of just under $900k is immaterial for a company with a market capitalization of $40.48 billion. The transaction represents a tiny fraction (0.0022%) of the company's total market value.
- Ownership Concentration: The insider sold all American Depositary Shares acquired through the option exercise but continues to hold 57,226 Ordinary Shares directly. This was not a liquidation of their entire stake in the company.
- Transaction Significance: The transaction is classified as low significance. It is a common cashless exercise where an insider sells shares obtained from options to cover exercise costs, taxes, and realize profits. It is not indicative of a change in the insider's outlook on the company.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a routine, pre-planned type of sale and its value is insignificant relative to the company's market cap. It provides no new information to the market.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is too small to impact trading volume.
- Sentiment Indicator: Neutral. The market typically views such exercise-and-sell transactions as compensation-related and not as a bearish signal.
Additional Context
Transaction Notes
- Special Circumstances: The filing details a multi-step transaction: the insider exercised options to acquire 2,627 American Depositary Shares (ADSs) and subsequently sold all 2,627 ADSs in two separate blocks. Each ADS represents 13 Ordinary Shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
